Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 4/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.49 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | CDC25B | P30305 | 5/20 | 0.45 |
| ▸ | GJA1 | P17302 | 3/20 | 0.45 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4925030 | 0.93 | PTPN1 (0.51) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL7079632 | 0.91 | NT5E (0.52) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL7593999 | 0.88 | PTPN1 (0.46) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL22677759 | 0.87 | NT5E (0.48) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL5198380 | 0.85 | TACR2 (0.51) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL5198375 | 0.85 | TACR2 (0.51) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL24371822 | 0.85 | NT5E (0.60) | NT5EPTPN1PTPN2PTPN11TACR2 | |
| SCHEMBL5476248 | 0.85 | NT5E (0.57) | NT5EPTPN1PTPN2PTPN11TACR2 | |
| SCHEMBL14414816 | 0.85 | NT5E (0.57) | NT5EPTPN1PTPN2PTPN11TACR2 | |
| SCHEMBL5470888 | 0.85 | NT5E (0.57) | NT5EPTPN1PTPN2PTPN11TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1252171-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR S.A. (FR) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001057053-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR (FR) | 2001-08-09 | — | — | WO | disclosed |